Our findings suggest that ICT may modulate the activities of Nrf2, HO-1 protein, and SOD, activate endogenous protective mechanisms against oxidative stress injury, and thus provide viable neuroprotectants and potential treatments for neurodegenerative diseases. This evidence concerns the gene NFE2L2 and neurodegenerative disease.